<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>36(1)</volume><submitter>Urbanczyk JP</submitter><pubmed_abstract>Ventricular septal defect (VSD) rarely occurs following transcatheter aortic valve implantation (TAVI). We report two patients who developed VSD following TAVI. One case was a Gerbode defect treated by percutaneous closure, and the second was a restrictive perimembranous VSD managed conservatively.</pubmed_abstract><journal>Proceedings (Baylor University. Medical Center)</journal><pagination>106-108</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9762799</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Iatrogenic ventricular septal defects following transcatheter aortic valve implantation.</pubmed_title><pmcid>PMC9762799</pmcid><pubmed_authors>Konda S</pubmed_authors><pubmed_authors>Caldera AE</pubmed_authors><pubmed_authors>Urbanczyk JP</pubmed_authors><pubmed_authors>Mixon TA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Iatrogenic ventricular septal defects following transcatheter aortic valve implantation.</name><description>Ventricular septal defect (VSD) rarely occurs following transcatheter aortic valve implantation (TAVI). We report two patients who developed VSD following TAVI. One case was a Gerbode defect treated by percutaneous closure, and the second was a restrictive perimembranous VSD managed conservatively.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-18T13:09:07.865Z</modification><creation>2025-04-06T22:40:39.639Z</creation></dates><accession>S-EPMC9762799</accession><cross_references><pubmed>36578605</pubmed><doi>10.1080/08998280.2022.2119543</doi></cross_references></HashMap>